Jun 18, 2024 9:00am EDT Lexaria Awards CRO Contract for 12-Week DehydraTECH GLP-1 Chronic Human Study
May 21, 2024 9:20am EDT Lexaria Receives Two New Medical-Treatment Patents in Hypertension and Epilepsy
May 06, 2024 9:05am EDT Lexaria Announces New Research Program to Evaluate Mode of Action and Performance of DehydraTECH-GLP-1 Drugs
Apr 30, 2024 3:40pm EDT Lexaria to Receive $4.7 Million Gross Proceeds in Warrant Exercise and Issuance